This pharmaceutical company operates across key European markets including major EU countries, focusing on developing and manufacturing a range of prescription medications. They possess a strong track record in delivering innovative therapies within specific disease areas such as oncology, cardiology, and respiratory illnesses. Their product portfolio includes various dosage forms like tablets and capsules, adhering to rigorous GMP certifications. The company holds several patents on its products, contributing to their competitive advantage in the market.